Mark Lakshmanan
Publications by Year
Research Areas
Diabetes Treatment and Management, Metabolism, Diabetes, and Cancer, Diabetes Management and Research, Pharmacology and Obesity Treatment, Estrogen and related hormone effects
Most-Cited Works
- → Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial(2019)2,890 cited
- → Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial(2018)621 cited
- → Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial(2019)610 cited
- → Teriparatide for acceleration of fracture repair in humans: A prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures(2009)505 cited
- → Efficacy and Safety of Dulaglutide Added Onto Pioglitazone and Metformin Versus Exenatide in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-1)(2014)378 cited
- → Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial(2020)266 cited
- → Design and baseline characteristics of participants in the R esearching cardiovascular E vents with a W eekly IN cretin in D iabetes ( REWIND ) trial on the cardiovascular effects of dulaglutide(2017)184 cited
- → The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial(2020)140 cited
- → HbA1c Change and Diabetic Retinopathy During GLP-1 Receptor Agonist Cardiovascular Outcome Trials: A Meta-analysis and Meta-regression(2020)137 cited
- → The effect of teriparatide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral fractures(2011)134 cited